All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

@draycakaya's weight loss claims need context

Ayça Kaya

Instagram creator

68.3K viewsView on Instagram

Quick answer

Weight loss of 57 kg over 2 years is possible with intensive interventions like bariatric surgery or high-dose GLP-1 receptor agonists, but zero weight regain is statistically unlikely. Most evidence-based interventions show 5-15% body weight reduction with some degree of regain over time.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

TRT social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 6 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For @draycakaya's weight loss claims need context, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Video claim decision path

Turn the claim into a safer next question

Direct answer

@draycakaya's weight loss claims need context should be treated as a claim to verify, then compared with evidence, safety context, and a provider review path.

Evidence check

Social clips are useful prompts, but they rarely show the full evidence base, contraindications, or dosing context.

Safety check

A viral claim can miss patient-specific risks, medication interactions, legal access, and source quality.

Next step

If the claim matches your goal, use the get-started flow to move from curiosity into a supervised prescription review.

Claim path

Keep researching this testosterone and trt video claims cluster

Best for searchers turning TRT social claims into a safer lab-backed provider discussion.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "@draycakaya's weight loss claims need context" from Ayça Kaya. We read the clip as a TRT social video fact-checks claim about Testosterone, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: Weight loss of 57 kg over 2 years is possible with intensive interventions like bariatric surgery or high-dose GLP-1 receptor agonists, but zero weight regain is statistically unlikely.

The reason this review is not generic is the source wording and the canonical claim label "trt tam 2 y l nce can m snmyncr78 imle 57 kg vermi tikkkk." In this clip, the useful excerpt is: "Tam 2 yıl önce Canım @snmyncr78 'imle -57 kg vermiştikkkk💪💪💪 Veee 2 yıldır hiç geri kilo almadıkkkk🥰💕💪🧿 Canım @fatmademirturgut 'umun röportajı ileeee yarın TRT HABERDEYİZ💕💕💕 Bekleniyors" That wording changes the review because it points to Testosterone evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against Once-Weekly Semaglutide in Adults with Overweight or Obesity (2021), Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance (2021), and Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight (2022), plus the creator's own wording. Testosterone decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

Zero weight regain over 2 years is statistically improbable based on long-term outcome studies across all intervention types
People who land here are usually comparing the Testosterone claim with kalıcızayıflama, diyet, and haber.
The strongest next step is to compare the claim with FormBlends' Testosterone guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

Weight loss of 57 kg over 2 years is possible with intensive interventions like bariatric surgery or high-dose GLP-1 receptor agonists, but zero weight regain is statistically unlikely.

FormBlends verdict

Testosterone evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • Weight loss of 57 kg over 2 years is possible with intensive interventions like bariatric surgery or high-dose GLP-1 receptor agonists, but zero weight regain is statistically unlikely. Most evidence-based interventions show 5-15% body weight reduction with some degree of regain over time.
  • Large weight losses (50+ kg) are possible but typically require intensive medical interventions like surgery or high-dose medications
  • Zero weight regain over 2 years is statistically improbable based on long-term outcome studies across all intervention types

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • Large weight losses (50+ kg) are possible but typically require intensive medical interventions like surgery or high-dose medications
  • Zero weight regain over 2 years is statistically improbable based on long-term outcome studies across all intervention types
  • The STEP 1 trial showed 14.9% average weight loss with semaglutide, but individual results vary dramatically
  • Successful weight maintenance typically requires permanent lifestyle changes and often continued medical treatment
  • Single patient testimonials don't represent typical outcomes and can create unrealistic expectations
  • Evidence-based weight loss expectations are 5-10% of body weight for most medical interventions
  • Long-term weight maintenance success requires ongoing behavioral strategies like daily weighing and regular exercise

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What does this video actually claim?

Dr. Ayça Kaya (@draycakaya) claims she helped a patient lose 57 kg over 2 years with no weight regain. She's promoting an upcoming TV interview about "permanent weight loss" and uses hashtags suggesting this involves diet and medical intervention.

The post lacks specifics about methods, timeline details, or patient characteristics. It's essentially a before-and-after testimonial dressed up as medical expertise.

Is 57 kg weight loss in 2 years realistic?

Yes, but it depends entirely on starting weight and methods used. For someone starting at 150+ kg, losing 57 kg represents a 38% body weight reduction, which falls within ranges seen in bariatric surgery studies.

The Longitudinal Assessment of Bariatric Surgery (LABS) consortium found average weight loss of 31.5% at 3 years post-surgery. Some GLP-1 receptor agonists show impressive results too. The STEP 1 trial (Wilding et al., NEJM, 2021) demonstrated 14.9% weight loss with 2.4mg semaglutide at 68 weeks.

Without knowing this patient's starting weight, intervention type, or medical history, we can't assess whether 57 kg loss is remarkable or expected.

What about the "no weight regain" claim?

This is where things get suspicious. Weight regain is extremely common regardless of intervention method. The claim of zero regain over 2 years is statistically improbable.

Long-term studies consistently show weight regain. Even with bariatric surgery, patients typically regain 15-25% of lost weight by 2-5 years post-procedure. The Look AHEAD trial showed that intensive lifestyle interventions led to 6% weight loss at 1 year, but only 2.5% at 8 years.

For pharmacotherapy, the STEP 1 extension data shows some regain when patients discontinue treatment. Perfect maintenance is rare, not typical.

Why are these testimonials problematic?

Single patient stories don't represent typical outcomes. This type of content violates evidence-based medicine principles by presenting exceptional cases as standard results.

The European Association for the Study of Obesity emphasizes that realistic weight loss expectations are 5-10% of body weight for most interventions. Promoting dramatic outliers without context misleads patients about probable outcomes.

Social media testimonials also can't account for confounding factors like concurrent medical treatments, genetic predisposition, or socioeconomic variables that influence weight management success.

What should you actually know about weight maintenance?

Successful long-term weight maintenance requires ongoing intervention, not a finite treatment period. The National Weight Control Registry tracks people who've maintained 30+ pound losses for over a year.

Their data shows successful maintainers typically weigh themselves daily, exercise 60-90 minutes per day, eat breakfast regularly, and limit TV watching. These behaviors must continue indefinitely.

For medical interventions, maintenance often requires continued treatment. Stopping GLP-1 agonists typically leads to weight regain. The realistic goal isn't perfection but minimizing regain through sustainable lifestyle changes and ongoing medical support when appropriate.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Ayça Kaya · Instagram creator

68.3K views on this video

Tam 2 yıl önce Canım @snmyncr78 ‘imle -57 kg vermiştikkkk💪💪💪 Veee 2 yıldır hiç geri kilo almadıkkkk🥰💕💪🧿 Canım @fatmademirturgut ‘umun röportajı ileeee yarın TRT HABERDEYİZ💕💕💕 Bekleniyors

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about large weight losses (50+ kg)?

Large weight losses (50+ kg) are possible but typically require intensive medical interventions like surgery or high-dose medications

What does the video say about zero weight regain over 2 years?

Zero weight regain over 2 years is statistically improbable based on long-term outcome studies across all intervention types

What does the video say about the step 1 trial showed 14.9% average weight loss with?

The STEP 1 trial showed 14.9% average weight loss with semaglutide, but individual results vary dramatically

What does the video say about successful weight maintenance typically requires permanent lifestyle changes?

Successful weight maintenance typically requires permanent lifestyle changes and often continued medical treatment

What does the video say about single patient testimonials don't represent typical outcomes?

Single patient testimonials don't represent typical outcomes and can create unrealistic expectations

What does the video say about evidence-based weight loss expectations?

Evidence-based weight loss expectations are 5-10% of body weight for most medical interventions

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by Ayça Kaya, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.